Zobrazeno 1 - 10
of 51
pro vyhledávání: '"David, Melnick"'
Autor:
Madhuri V. Nishtala, MD, Aos S. Karim, MD, David Melnick, MD, Therese Delarwelle, RN, Elise Lawson, MD, Caprice C. Greenberg, MD, MPH, Tudor Borza, MD, MS
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 3, p e313 (2023)
Externí odkaz:
https://doaj.org/article/97d5079b052f494a8be6a3e7d80ab011
Autor:
Zaid Nabulsi, Andrew Sellergren, Shahar Jamshy, Charles Lau, Edward Santos, Atilla P. Kiraly, Wenxing Ye, Jie Yang, Rory Pilgrim, Sahar Kazemzadeh, Jin Yu, Sreenivasa Raju Kalidindi, Mozziyar Etemadi, Florencia Garcia-Vicente, David Melnick, Greg S. Corrado, Lily Peng, Krish Eswaran, Daniel Tse, Neeral Beladia, Yun Liu, Po-Hsuan Cameron Chen, Shravya Shetty
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Chest radiography (CXR) is the most widely-used thoracic clinical imaging modality and is crucial for guiding the management of cardiothoracic conditions. The detection of specific CXR findings has been the main focus of several artificial i
Externí odkaz:
https://doaj.org/article/31c65be9be1043d9a386af4cf67b5c5c
Autor:
Josh Bleicher, Jordan E. Johnson, Brian T. Cain, Robert D. Shaw, Alexandra A. Acher, Lauren Gleason, Richard J. Barth, Daniel I. Chu, Sarah Jung, David Melnick, Kimberly A. Kaphingst, Brigitte K. Smith, Lyen C. Huang
Publikováno v:
Journal of Surgical Education. 80:786-796
Autor:
Paul B, Eckburg, Lori, Muir, Ian A, Critchley, Susannah, Walpole, Hanna, Kwak, Anne-Marie, Phelan, Gary, Moore, Akash, Jain, Tim, Keutzer, Aaron, Dane, David, Melnick, Angela K, Talley
Publikováno v:
New England Journal of Medicine. 386:1327-1338
There is a need for oral antibiotic agents that are effective against multidrug-resistant gram-negative uropathogens. Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales, including
Autor:
Ian A Critchley, Paul B Eckburg, Lori A Muir, Aaron Dane, Gary E Moore, David Melnick, Angela K Talley
Publikováno v:
Open Forum Infectious Diseases. 9
Background Enterobacterales (ENT) are frequently implicated in complicated urinary tract infection, including acute pyelonephritis (cUTI/AP), with Escherichia coli (EC) being the most prevalent. Extended-spectrum β-lactamase (ESBL)-producing organis
Autor:
Angela K Talley, Paul B Eckburg, Ian A Critchley, Gary E Moore, Nivedita Bhatt, Lori A Muir, David Melnick
Publikováno v:
Open Forum Infectious Diseases. 9
Background Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an oral carbapenem with activity against Enterobacterales uropathogens, including drug resistant strains. The ADAPT-PO trial demonstrated the non-inferiority of oral TBP-PI-HBr vs. intravenous
Autor:
Neil Bahroos, Subhash Kumar Kolar Rajanna, Stephen B. Brown, Padma Thangaraj, David Melnick, Angela Freeman
Publikováno v:
Journal of Clinical and Translational Science, Vol 1, Pp 21-22 (2017)
OBJECTIVES/SPECIFIC AIMS: This research project envisions the integration of Homeless Management Information System (HMIS) and UI Health Cerner electronic medical record (EMR) system with the following goals: (1) enable sharing of data about the stat
Externí odkaz:
https://doaj.org/article/38b61c9b1abf42bcbf9bd04c4bc702f1
Autor:
Suzanne Stokes, Grayson Moore, Erika Manyak, Myriah M Satterfield, Vipul K Gupta, Aaron Dane, Archie Thurston, David Melnick, Angela K Talley
Publikováno v:
Antimicrobial Agents and Chemotherapy
SPR720 (phosphate prodrug of SPR719) is a novel aminobenzimidazole bacterial DNA gyrase (GyrB) inhibitor in development for nontuberculous mycobacterial pulmonary disease (NTM-PD) and pulmonary tuberculosis. SPR719 has demonstrated activity against c
Publikováno v:
Antimicrobial Agents and Chemotherapy
Carbapenem-resistant Acinetobacter baumannii and Enterobacterales are identified as urgent threats, and multidrug-resistant (MDR) Pseudomonas aeruginosa and extended-spectrum beta-lactamase (ESBL)-producing pathogens are identified as serious threats
Publikováno v:
Open Forum Infectious Diseases
Background Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an oral prodrug that is converted to tebipenem (TBP), the active moiety. TBP is a carbapenem with activity against multidrug-resistant Gram-negative pathogens, including extended-spectrum-β-l